Isolated Versus Synergetic Muscle Facilitation on Upper Limb Functional Performance in Acute Stroke

ConditionAcute Stroke
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-60
SponsorCairo University

About this trial

This study is a randomized controlled clinical trial that will be carried out to investigate the effect of isolated versus synergetic muscle facilitation on upper limb functional performance in patients with acute stroke.

RESEARCH QUESTION:

Is there a difference between isolated and synergetic muscle facilitation on upper limb functional performance in patients with acute stroke?

It will be hypothesized that:

There will be no difference between isolated and synergetic muscle facilitation on upper limb task-oriented training in patients with acute stroke.

Treatment procedures:

Study group (A): patients will receive a physical therapy program in the form of a range of motion exercise, electrical muscle stimulation, stretching exercise, mental practice with motor imagery, and isolated muscle facilitation using electromyography (EMG) biofeedback for six weeks and followed by task-oriented training of the upper limb for six weeks control group (B): will receive a standard physical therapy program including range of motion exercise, electrical muscle stimulation, Mental practice with motor imagery and stretching exercise, synergetic muscle facilitation for six weeks, and followed by task-oriented training of the upper limb for six weeks.

Eligibility criteria

Qualifiers

Unilateral Middle cerebral artery (MCA) stroke patients

Brunnstrom stage of recovery 1& 2

Normal body mass index (18.5 - 24.99 kg/m2)

Dominant handedness

Disqualifiers

Perceptual, apraxia, major cognitive deficits

Recurrent stroke

Subjects with cerebellar lesions, painful or subluxated shoulder, any contracture or deformity of the upper extremity

Trial design

Treatments tested in this trial

  • standard physical therapy program
  • isolated muscle facilitation
  • synergetic muscle facilitation program

Treatment groups

40 Participants
are divided into 2 treatment groups

Sponsors and collaborators